(Total Views: 491)
Posted On: 10/30/2019 1:10:43 PM
Post# of 155096
Wow, peak global sales of $1.5B annually and the same drug with to treat another rare disease with the readout expected soon. Their share structure is much different than CYDY, but $6.2B market cap compared to $116M simply based on expected market potential seems crazy out of line (even trading on the OTC).
https://www.cnbc.com/video/2019/10/15/reata-s...sults.html
https://www.cnbc.com/video/2019/10/15/reata-s...sults.html
(1)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
